Compounding pharmacies eager to cash in on the peptide boom are watching closely as the nation’s top health official pushes to legalize the market. A regulatory minefield may mean a long wait.
Experts told Law360 that Health and Human Services Secretary Robert F. Kennedy Jr. appears to be avoiding “politically unsavory” issues and focusing on more popular health policies across his hearings this week. Here, Law360 looks at experts' three takeways.
A case headed to the U.S. Supreme Court next week could roll back a legal doctrine that physicians say is key to protecting them from frivolous medical malpractice suits filed by patients who've already lost in state court.
Previous
Next
Compounding pharmacies eager to cash in on the peptide boom are watching closely as the nation’s top health official pushes to legalize the market. A regulatory minefield may mean a long wait.
Experts told Law360 that Health and Human Services Secretary Robert F. Kennedy Jr. appears to be avoiding “politically unsavory” issues and focusing on more popular health policies across his hearings this week. Here, Law360 looks at experts' three takeways.
A case headed to the U.S. Supreme Court next week could roll back a legal doctrine that physicians say is key to protecting them from frivolous medical malpractice suits filed by patients who've already lost in state court.
-
April 30, 2026
The Trump administration said late Wednesday that it's appealing a court order that stopped its pared-down childhood vaccine schedule from going into effect.
-
April 29, 2026
The former CEO of a California-based pharmaceutical company agreed Wednesday to pay the U.S. Securities and Exchange Commission $30,000 to end a lawsuit accusing him of misappropriating $3.2 million in company funds partly to buy a Beverly Hills mansion.
-
April 29, 2026
Pharmaceutical giant Novo Nordisk told a Texas federal judge that it does not control the GLP-1 market and has not attempted to crush its competition in a bid to dismiss an antitrust suit it is facing.
-
April 29, 2026
Pharmacy benefit managers Express Scripts, Evernorth Health and Prime Therapeutics have bolstered their effort to escape a federal price-fixing suit brought against them by Michigan's attorney general by arguing the statutes cited in the complaint do not apply to them.
-
April 29, 2026
A Texas-headquartered health insurance agency will pay $5 million to settle allegations that it engaged in deceptive and unfair marketing to sell plans and other types of health programs to thousands of Massachusetts consumers, the state's attorney general announced on Wednesday.
-
April 29, 2026
The full Fifth Circuit will reconsider insurance company Aetna's bid to force uniform and food services company Aramark to arbitrate its dispute over employee health benefit claims, staying a panel's ruling from December that had kept proceedings in court.
-
April 29, 2026
When the federal government included Botox in Medicare's drug price negotiation program, which allows Medicare officials to negotiate for lower drug prices, it overstepped its authority, drugmaker AbbVie Inc. told a D.C. federal court, arguing the cosmetic drug and migraine treatment is a "plasma-derived" product ineligible for price controls.
-
April 29, 2026
Patients who claim Pennsylvania-based AdaptHealth Corp. overcharged them for returned medical equipment have reached the final version of a class settlement and will soon submit it to a North Carolina federal court for approval, they told the court this week.
-
April 29, 2026
The U.S. Supreme Court on Wednesday unanimously revived an anti‑abortion pregnancy center network's constitutional challenge to a New Jersey subpoena seeking years of donor information, holding that the state's demand infringed free speech.
-
April 28, 2026
The Ohio Supreme Court held Tuesday that a state law establishing parental rights for the spouse of a woman who conceives a child through artificial insemination doesn't retroactively apply to same-sex couples when a child was born before gay marriage was legalized by the U.S. Supreme Court in 2015.
-
April 28, 2026
Federal prosecutors have charged a former adviser to Dr. Anthony Fauci with deleting government emails and using his personal email account to dodge public records requests about the origins of the COVID-19 virus.
-
April 28, 2026
OxyContin maker Purdue Pharma LP has to pay a $3.5 billion fine and forfeit an additional $2 billion, more than five years after it pled guilty to criminal charges related to its role in the opioid crisis, a New Jersey federal judge said Tuesday.
-
April 28, 2026
The Trump administration's plans to promulgate new regulations governing mental health parity requirements for employee health plans are currently causing headaches for attorneys, but a rule that includes specific examples could ultimately ease compliance burdens for benefit plan sponsors.
-
April 28, 2026
While the volume of malpractice lawsuits against U.S. physicians has dropped in recent years, that doesn't mean the threat of legal liability is dissipating, according to a report released Monday by the American Medical Association.
-
April 28, 2026
A Michigan health system agreed to pay $1.9 million to resolve a suit claiming it failed to kick an underperforming investment fund from its workers' retirement plan, causing employees to lose out on millions in savings.
-
April 28, 2026
Louisiana's attorney general has sued over mifepristone, pursued charges against out-of-state doctors and sparred with drugmakers. Liz Murrill talks to Law360 Healthcare Authority about her approach to healthcare and the law.
-
April 28, 2026
A North Carolina federal judge should let a tobacco workers' union keep its win in a retiree healthcare fight with the company that makes Winston and Salem cigarettes, the union argued, saying the company's challenge to a November arbitration award can't proceed because it wasn't properly filed.
-
April 28, 2026
A Maryland couple can pursue a proposed class action against a health insurer that they say wrongfully denied coverage for embryo thawing in connection with an in vitro fertilization procedure, the Maryland Supreme Court has ruled, finding that the insurer's subsequent payment of the claim doesn't moot the suit.
-
April 28, 2026
When the U.S. Supreme Court hears arguments Wednesday in a patent case involving "skinny labels" on generic drugs, a longtime patent attorney as well as a government attorney who often handles intellectual property cases will face an appellate specialist who has argued many high court cases.
-
April 27, 2026
A North Dakota federal judge on Monday blocked the state's new drug-pricing law, agreeing with pharmaceutical companies that while the law purports to "protect the underdogs," it illegally interferes with the federal drug-pricing regime.
-
April 27, 2026
The U.S. Department of Justice waded into a dispute between pharmaceutical giants and the state of Washington on Monday, arguing that federal law preempts a new state law that expands discounts that drugmakers must provide under the federal 340B Drug Pricing Program.
-
April 27, 2026
A Wyoming judge has blocked enforcement of the latest effort by state lawmakers to enact a rigid anti-abortion law, after the Wyoming Supreme Court in January struck down the state's previous near-total ban on abortion.
-
April 27, 2026
California appellate justices refused to reinstate a "General Hospital" actor's suit alleging ABC fired him for his political views after he declined to comply with its COVID-19 vaccine policy, ruling the evidence shows that the ultimate decision-makers who ended his employment agreement didn't know about his political views.
-
April 27, 2026
A company purportedly focused on using traditional Chinese medicine to treat conditions including autism spectrum disorder faces a proposed investor class action alleging it downplayed the risk it would be probed in connection with unusual volatility affecting the market for its shares.
-
April 27, 2026
The government failed to prove the former owner of a mental health counseling company in Virginia willfully committed fraud by falsely billing Medicaid $200,000 for counseling services on two specific dates, a panel of the Fourth Circuit has found, overturning his convictions.